Targeting Mitochondrial Cell Death Pathway to Overcome Drug Resistance with a Newly Developed Iron Chelate
Avishek Ganguly, Soumya Basu, Paramita Chakraborty et al. · 2010
Read Targeting Mitochondrial Cell Death Pathway to Overcome Drug Resistance with a Newly Developed Iron Chelate by Avishek Ganguly, Soumya Basu, Paramita Chakraborty et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011253.txt.
Description
Ganguly, Basu, Chakraborty and colleagues attacked drug resistant cancer in PLOS ONE in 2010. Some tumors survive standard drugs by refusing to die on cue. The team used a newly developed iron binding compound aimed at the cell death pathway housed in mitochondria, the cell's power plants.
Triggering death through that route overcame resistance in their tests. Hitting the power plant sidesteps defenses that block other drugs at the cell surface. The approach offers a treatment plan for tumors that have exhausted common options. Further work must show the compound is safe in healthy tissue as well.
Catalog record
| CREATOR | Avishek Ganguly, Soumya Basu, Paramita Chakraborty et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011253